What is Retatrutide peptide?
Retatrutide (LY3437943) is a synthetic triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors simultaneously. It is supplied as a lyophilised research peptide and is studied for its effects on metabolic pathways including appetite regulation, glucose homeostasis, and energy expenditure.
What is the difference between Retatrutide and Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Retatrutide adds a third receptor target — the glucagon receptor — making it a triple agonist. The glucagon component is associated with increased energy expenditure through thermogenesis, which dual agonists do not address to the same degree in published research.
What is the Retatrutide dosage used in research?
Published Phase 2 trial data used weekly subcutaneous doses ranging from 1 mg to 12 mg, with dose escalation every four weeks. Available research vials from EvoPeak are 10 mg, 15 mg, 20 mg, and 30 mg. All dosage information is for research reference only.
What are the side effects of Retatrutide?
Published research reports gastrointestinal effects (nausea, vomiting, diarrhoea) as the most common, particularly during dose initiation. Injection site reactions, appetite suppression, and modest heart rate increases have also been documented in trial data. Severity is generally mild to moderate and dose-dependent.
What is Reta peptide?
Reta is a common abbreviation for Retatrutide in research communities. Reta peptide refers to the same triple agonist compound (LY3437943) targeting GLP-1, GIP, and glucagon receptors.
How do I reconstitute Retatrutide?
Reconstitute lyophilised Retatrutide with bacteriostatic water. Inject diluent slowly down the vial wall without shaking. Store reconstituted peptide at 2–8°C and unused lyophilised powder at −20°C. Bacteriostatic water is available from EvoPeak.
Can I buy Retatrutide in Australia?
Yes. EvoPeak supplies research-grade Retatrutide peptide to Australian researchers with HPLC/MS verification, batch-specific COA documentation, and domestic shipping. Products are for laboratory research use only.
How much does Retatrutide cost in Australia?
EvoPeak Retatrutide is priced at $149 AUD for a 10 mg vial, $199 AUD for 15 mg, $229 AUD for 20 mg, and $299 AUD for 30 mg. Prices include GST and cover third-party HPLC/MS testing with batch-specific COA documentation. All pricing is for research compounds only.
Where can I buy Retatrutide peptide in Australia?
Order directly from the EvoPeak shop page at evopeak.io/shop/retatrutide. Select your preferred vial size (10 mg, 15 mg, 20 mg, or 30 mg), review the COA, and checkout with PayID for local Australian fulfilment. Same-day dispatch is available for orders placed before the daily cutoff.
Is Retatrutide for sale to Australian researchers?
Yes — Retatrutide is available for purchase by Australian researchers through EvoPeak. All products are sold strictly for laboratory research use and are not intended for human consumption, injection, or therapeutic use.
How do I get Retatrutide in Australia for research?
Order directly from the EvoPeak shop page. Select your preferred vial size (10 mg, 15 mg, 20 mg, or 30 mg), review the COA, and checkout with local Australian fulfilment. Same-day dispatch is available for orders placed before the daily cutoff.
Is Retatrutide the same as Semaglutide or Tirzepatide?
No. Semaglutide is a single GLP-1 agonist. Tirzepatide is a dual GIP/GLP-1 agonist. Retatrutide is a triple agonist adding glucagon receptor activation. Each represents a distinct generation of incretin research compounds with different receptor target profiles.
What purity standard does EvoPeak Retatrutide meet?
Every batch undergoes HPLC purity analysis (targeting >99%), mass spectrometry identity verification, and endotoxin screening (LAL test). Batch-specific certificates of analysis are available for download on the product page.
